Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Chris Lange | Nov 12, 2014 at 8:40 AM EST

Biotech Short Interest Becomes Stock Specific (Updated)

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.

Lee Jackson | Oct 30, 2014 at 8:55 AM EDT

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to…

Jon C. Ogg | Oct 29, 2014 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, October 29, 2014.

Paul Ausick | Oct 27, 2014 at 4:33 PM EDT

Amgen Posts 52-Week High, Beats It Again After Earnings

Amgen reported better-than-expected third-quarter 2014 results after markets closed Monday afternoon.

Chris Lange | Oct 27, 2014 at 10:30 AM EDT

Biotech Short Interest Becomes Stock Specific

Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.

Jon C. Ogg | Oct 21, 2014 at 4:22 PM EDT

The Plan to Drive Amgen Shares Up Over 70%

Jon OggAmgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is…

Lee Jackson | Oct 13, 2014 at 8:40 AM EDT

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech…

Chris Lange | Oct 10, 2014 at 10:10 AM EDT

Short Interest in Biotech Becomes Company Specific

The short interest data are out for the end of September settlement date, and 24/7 Wall St. has reviewed the…

Lee Jackson | Sep 29, 2014 at 8:30 AM EDT

3 Likely Biotech Buyout Candidates

A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could…

Jon C. Ogg | Sep 25, 2014 at 10:50 AM EDT

Short Sellers Make Moves in Key Biotech Stocks

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most…

247alex | Sep 25, 2014 at 6:12 AM EDT

10 Companies Cutting the Most Jobs

Through August, planned job cuts were slightly lower than they were during the first eight months of 2013. In all,…

Chris Lange | Sep 11, 2014 at 9:20 AM EDT

Short Sellers Remain Vigilant Against Biotechs

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…

Lee Jackson | Sep 9, 2014 at 8:30 AM EDT

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy…

Chris Lange | Aug 27, 2014 at 10:25 AM EDT

Rising Short Interest in Biotech Stocks

Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts.

Lee Jackson | Aug 18, 2014 at 9:00 AM EDT

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

ThinkstockMost firms we cover on Wall Street have quantitative strategies for their clients, and often they use similar formulas to…

1 … 27 28 29 30 31 … 47

Amgen : AMGN

All Amgen Articles

Biotech Short Interest Becomes Stock Specific (Updated)

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More

Amgen Posts 52-Week High, Beats It Again After Earnings

Biotech Short Interest Becomes Stock Specific

The Plan to Drive Amgen Shares Up Over 70%

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Short Interest in Biotech Becomes Company Specific

3 Likely Biotech Buyout Candidates

Short Sellers Make Moves in Key Biotech Stocks

10 Companies Cutting the Most Jobs

Short Sellers Remain Vigilant Against Biotechs

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Rising Short Interest in Biotech Stocks

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Amgen : AMGN

All Amgen Articles

Biotech Short Interest Becomes Stock Specific (Updated)

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More

Amgen Posts 52-Week High, Beats It Again After Earnings

Biotech Short Interest Becomes Stock Specific

The Plan to Drive Amgen Shares Up Over 70%

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Short Interest in Biotech Becomes Company Specific

3 Likely Biotech Buyout Candidates

Short Sellers Make Moves in Key Biotech Stocks

10 Companies Cutting the Most Jobs

Short Sellers Remain Vigilant Against Biotechs

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Rising Short Interest in Biotech Stocks

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%